HUP0101057A2 - D1/D5 antagonisták alkalmazása rögeszmés kényszerképzetes zavarok, szomatoform zavarok, tudathasadásos étkezési zavarok, impulzív viselkedési zavarok és autizmus kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents
D1/D5 antagonisták alkalmazása rögeszmés kényszerképzetes zavarok, szomatoform zavarok, tudathasadásos étkezési zavarok, impulzív viselkedési zavarok és autizmus kezelésére szolgáló gyógyszerkészítmények előállításáraInfo
- Publication number
- HUP0101057A2 HUP0101057A2 HU0101057A HUP0101057A HUP0101057A2 HU P0101057 A2 HUP0101057 A2 HU P0101057A2 HU 0101057 A HU0101057 A HU 0101057A HU P0101057 A HUP0101057 A HU P0101057A HU P0101057 A2 HUP0101057 A2 HU P0101057A2
- Authority
- HU
- Hungary
- Prior art keywords
- disorders
- autism
- pharmaceutical compositions
- somatoform
- dissociative
- Prior art date
Links
- 206010003805 Autism Diseases 0.000 title abstract 2
- 208000020706 Autistic disease Diseases 0.000 title abstract 2
- 208000030814 Eating disease Diseases 0.000 title abstract 2
- 208000019454 Feeding and Eating disease Diseases 0.000 title abstract 2
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 title abstract 2
- 208000027520 Somatoform disease Diseases 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 235000014632 disordered eating Nutrition 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000026331 Disruptive, Impulse Control, and Conduct disease Diseases 0.000 title 1
- 208000030990 Impulse-control disease Diseases 0.000 title 1
- 208000022540 Consciousness disease Diseases 0.000 abstract 1
- 206010021567 Impulsive behaviour Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000035474 group of disease Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000003252 repetitive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány tárgya olyan zavarok csoportjának a kezelésére szolgálógyógyszerkészítmények, amelyeket ismétlődő, erőszakos és/vagyritualista viselkedés, vagyis rögeszmés kényszerképzetes zavarok,szomatoform zavarok, tudathasadásos zavarok, étkezési zavarok,impulzív viselkedési zavarok és autizmus jellemeznek. Ezek agyógyszerkészítmények egy D1/D5 antagonista hatásos mennyiségéttartalmazzák. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3320598A | 1998-03-02 | 1998-03-02 | |
| PCT/US1999/003721 WO1999044615A1 (en) | 1998-03-02 | 1999-03-01 | Use of d1/d5 antagonists for treating obsessive compulsive disorders, somatoform disorders, dissociative, eating disorders, impulse control disorders and autism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101057A2 true HUP0101057A2 (hu) | 2001-08-28 |
| HUP0101057A3 HUP0101057A3 (en) | 2001-09-28 |
Family
ID=21869083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101057A HUP0101057A3 (en) | 1998-03-02 | 1999-03-01 | Use of d1/d5 antagonists for preparing pharmaceutical compositions for treating obsessive compulsive disorders, somatoform disorders, dissociative, eating disorders, impulse control disorders and autism |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1058551A1 (hu) |
| JP (1) | JP2002505291A (hu) |
| KR (1) | KR20010041477A (hu) |
| CN (1) | CN1291893A (hu) |
| AR (1) | AR018297A1 (hu) |
| AU (1) | AU2778099A (hu) |
| BR (1) | BR9908392A (hu) |
| CA (1) | CA2322201A1 (hu) |
| CO (1) | CO4910136A1 (hu) |
| HU (1) | HUP0101057A3 (hu) |
| IL (1) | IL137715A0 (hu) |
| NO (1) | NO20004363L (hu) |
| PE (1) | PE20000333A1 (hu) |
| SK (1) | SK12962000A3 (hu) |
| WO (1) | WO1999044615A1 (hu) |
| ZA (1) | ZA991638B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
| RU2374245C1 (ru) | 2008-08-22 | 2009-11-27 | Андрей Александрович Иващенко | Лиганд с широким спектром одновременной рецепторной активности, фармацевтическая композиция, способ ее получения и лекарственное средство |
| CA2879020C (en) * | 2012-07-12 | 2021-02-09 | Psyadon Pharmaceuticals, Inc. | Fused benzazepines for treatment of tourette's syndrome |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605897A (en) * | 1991-04-23 | 1997-02-25 | Eli Lilly And Company | 2-methyl-thieno-benzodiazepine |
-
1999
- 1999-03-01 WO PCT/US1999/003721 patent/WO1999044615A1/en not_active Application Discontinuation
- 1999-03-01 IL IL13771599A patent/IL137715A0/xx unknown
- 1999-03-01 CN CN99803496A patent/CN1291893A/zh active Pending
- 1999-03-01 BR BR9908392-2A patent/BR9908392A/pt not_active IP Right Cessation
- 1999-03-01 AU AU27780/99A patent/AU2778099A/en not_active Abandoned
- 1999-03-01 PE PE1999000169A patent/PE20000333A1/es not_active Application Discontinuation
- 1999-03-01 SK SK1296-2000A patent/SK12962000A3/sk unknown
- 1999-03-01 JP JP2000534217A patent/JP2002505291A/ja not_active Withdrawn
- 1999-03-01 ZA ZA9901638A patent/ZA991638B/xx unknown
- 1999-03-01 EP EP99908318A patent/EP1058551A1/en not_active Withdrawn
- 1999-03-01 AR ARP990100860A patent/AR018297A1/es unknown
- 1999-03-01 HU HU0101057A patent/HUP0101057A3/hu unknown
- 1999-03-01 KR KR1020007009634A patent/KR20010041477A/ko not_active Application Discontinuation
- 1999-03-01 CO CO99012525A patent/CO4910136A1/es unknown
- 1999-03-01 CA CA002322201A patent/CA2322201A1/en not_active Abandoned
-
2000
- 2000-09-01 NO NO20004363A patent/NO20004363L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010041477A (ko) | 2001-05-25 |
| JP2002505291A (ja) | 2002-02-19 |
| PE20000333A1 (es) | 2000-05-13 |
| NO20004363D0 (no) | 2000-09-01 |
| AR018297A1 (es) | 2001-11-14 |
| IL137715A0 (en) | 2001-10-31 |
| ZA991638B (en) | 1999-09-01 |
| WO1999044615A1 (en) | 1999-09-10 |
| AU2778099A (en) | 1999-09-20 |
| EP1058551A1 (en) | 2000-12-13 |
| CO4910136A1 (es) | 2000-04-24 |
| HUP0101057A3 (en) | 2001-09-28 |
| SK12962000A3 (sk) | 2001-08-06 |
| CN1291893A (zh) | 2001-04-18 |
| NO20004363L (no) | 2000-10-31 |
| CA2322201A1 (en) | 1999-09-10 |
| BR9908392A (pt) | 2000-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE225351T1 (de) | Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel | |
| HUP0000487A2 (hu) | Neurokinin antagonistaként alkalmazható szubsztituált oximszármazékok | |
| DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| DE60223694D1 (de) | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums | |
| NO20012977L (no) | N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet | |
| DE60103556D1 (de) | Zusammensetzungen zur behandlung von fettleibigkeit, welche antagonisten der cb1-rezeptoren und sibutramine enthalten | |
| DE50004334D1 (de) | Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane | |
| DE60123238D1 (de) | Zusammensetzungen zur behandlung von autoimmunkrankheiten | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| HUP0104688A2 (hu) | Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez | |
| ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
| ATE355067T1 (de) | 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation | |
| DE60228073D1 (de) | Adenosin-a1-rezeptorantagonisten zur behandlung von hypoxiebedingten lern- und gedächtnisstörungen | |
| ATE355054T1 (de) | Verfahren und verbindungen zur behandlung der depression | |
| DE60139783D1 (de) | Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen | |
| HUP0101057A2 (hu) | D1/D5 antagonisták alkalmazása rögeszmés kényszerképzetes zavarok, szomatoform zavarok, tudathasadásos étkezési zavarok, impulzív viselkedési zavarok és autizmus kezelésére szolgáló gyógyszerkészítmények előállítására | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| DE60142786D1 (de) | Zusammensetzungen und methoden zur behandlung von candidosen | |
| AU2002231777A1 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| ATE546154T1 (de) | Anti-angiogenetisches mittel und seine verwendung bei der krebsbehandlung | |
| ATE443060T1 (de) | Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit | |
| ATE343387T1 (de) | S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen. | |
| DE69926996D1 (de) | Verwendung von riluzol zur behandlung der retinalischemie | |
| ATE412423T1 (de) | Peroxiredoxin-arzneistoffe zur behandlung einer hiv-1-infektion | |
| DE60222143D1 (de) | Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom |